Europe Medical Cannabis Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Apr 2021
  • Europe
  • 350 Pages
  • No of Tables: 450
  • No of Figures: 51

Europe Medical Cannabis Market, By Product (Oil, Dried Medical Cannabis, Medical Cannabis Capsules, Vape Pen, Whole Flower, Creams & Moisturizer, Ground Flower, Patch, Mask & Serum, Cleanser, Others), Source (Natural, Synthetic), Species (Sativa, Hybrid, Cannabis Indica), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol, Cannabigerol (CBG), Cannabinol, Others), Application (Pain Management, Anxiety, Muscle Spasms, Nausea, Appetite Loss, Cancer, Arthritis, Alzheimer's Disease, Epilepsy, Depression and Sleep Disorders, Multiple Sclerosis, Autism, Mental Health Conditions, Elevate Mood, Others), Route of Administration (Oral Solutions and Capsules, Smoking, Topicals, Vaporizers, Others), End User (Homecare Settings, Hospital and Rehab Centers, Pharmaceutical Industry, Research and Development Centers, Others), Distribution Channel (B2C, B2B), Country (Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Rest of Europe) Industry Trends and Forecast to 2028

Europe Medical Cannabis Market

Market Analysis and Insights : Europe Medical Cannabis Market

The medical cannabis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 24.5% in the forecast period of 2021 to 2028 and is expected to reach USD 19,153.13 million by 2028. Increased medical use and legalization of cannabis is acting as a driver for the medical cannabis market.

Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally and has wide range of applications in treatment of various diseases including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS and Alzheimer’s among others.

The increased usage of cannabis in the cosmetic products can be seen as a driver for the medical cannabis market. Complex regulatory structure for usage of cannabis is a restraint for the medical cannabis market. Novel product development with increased R & D activities may act as an opportunity for the medical cannabis market. The rise of marijuana black market is a challenge for the medical cannabis market

The medical cannabis market provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the medical cannabis market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Medical Cannabis Market

Medical Cannabis Market Scope and Market Size

The medical cannabis market is categorized into eight notable segments which are based on the product, source, species, derivatives, application, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the medical cannabis market is segmented into oil, medical cannabis capsules, patch, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, mask & serum, cleanser and others. In 2021, oil segment is expected to dominate the medical cannabis market due to high technology adoption by key players in the market.
  • On the basis of source, the medical cannabis market is segmented into synthetic and natural. In 2021, synthetic segment is expected to dominate the medical cannabis market because of increasing healthcare expenditure. 
  • On the basis of species, the medical cannabis market is segmented into cannabis indica, sativa and hybrid. In 2021, cannabis indica segment is expected to dominate the medical cannabis market because of increased medicinal use of cannabis.
  • On the basis of derivatives, the medical cannabis market is segmented into cannabidiol (CBD), tetrahydrocannabinol (THC)/delta-8-tetrahydrocannabinol, cannabinol, cannabigerol (CBG) and others. In 2021, cannabidiol (CBD) segment is expected to dominate the medical cannabis market due to increasing demand of medical marijuana products in the market.
  • On the basis of application, the medical cannabis market is segmented into Alzheimer’s disease, appetite loss, cancer, epilepsy, autism, mental health conditions, multiple sclerosis, pain management, nausea, muscle spasms, arthritis, elevate mood, depression and sleep disorders, anxiety and others. In 2021, Alzheimer’s disease segment is expected to dominate the medical cannabis market because of increasing R&D activities.  
  • On the basis of route of administration, the medical cannabis market is segmented into oral solutions and capsules, smoking, vaporizers, topicals and others. In 2021, oral solutions and capsules segment is expected to dominate the medical cannabis market because of rising prevalence of chronic diseases.
  • On the basis of end user, the medical cannabis market is segmented into pharmaceutical industry, research and development centers, homecare settings, hospital and rehab centers and others. In 2021, pharmaceutical industry segment is expected to dominate the medical cannabis market because of increasing geriatric population and prevalence of chronic diseases.
  • On the basis of distribution channel, the medical cannabis market is segmented into B2B and B2C. In 2021, B2B segment is expected to dominate the medical cannabis market because of increasing demand of cannabis for medical and clinical purposes.

Europe Medical Cannabis Market Country Level Analysis

Europe medical cannabis market is analysed and market size information is provided by the country, product, source, species, derivatives, application, route of administration, end user and distribution channel as referenced above.

The countries covered in the Europe medical cannabis market report are the Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Belgium and rest of Europe.

Germany is dominating in the Europe medical cannabis market because of the high legalization of cannabis in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. 

New Product Launches by Manufacturers is creating new opportunities for Players in the Medical Cannabis Market

The medical cannabis market also provides you with detailed market analysis for every country growth in aesthetic industry with medical cannabis market sales, impact of advancement in the medical cannabis market and changes in regulatory scenarios with their support for the medical cannabis market. The data is available for historic period 2011 to 2019. 

Competitive Landscape and Medical Cannabis Market Share Analysis

The medical cannabis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Europe medical cannabis market.

The major players operating in the Europe medical cannabis market report are Tilray, Elixinol Europe Limited, Medical Marijuana, Inc., Peace Naturals Project Inc., BOL Pharma, PharmaHemp, Kiehl’s (a subsidiary of L'ORÉAL), ENDOCA, CANOPY GROWTH CORPORATION, Aurora Cannabis, GW Pharmaceuticals plc, Althea Company Pty Ltd (a subsidiary of Althea Group), Cresco Labs, IDT Australia, MediPharm Labs Inc., BARNEY'S FARM and Aphria Inc. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. 

Many product developments are also initiated by the companies worldwide which are also accelerating the growth of medical cannabis market.

For instance, 

  • In February 2021, MediPharm Labs Inc. received the Cannabis Drug License. This was considered a milestone as MediPharm Labs will now be able to carry out manufacturing and distribution of pharmaceuticals with cannabis as their component. This will help in driving the market growth in coming years.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the medical cannabis market which also provides the benefit for organisation to improve their offering for medical cannabis market.

Customization Available: Europe Medical Cannabis Market 

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 ANNUAL COST OF CULTIVATION:

TABLE 2 ANNUAL COST OF MANUFACTURING:

TABLE 3 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED

TABLE 26 EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 27 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 28 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 29 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY ANXIETY, BY REGION, 2021-2028 (USD MILLION)

TABLE 30 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 31 EUROPE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 32 EUROPE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 33 EUROPE NAUSEA IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 34 EUROPE NAUSEA IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 35 EUROPE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 36 EUROPE APPETITE LOSS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 37 EUROPE CANCER IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 38 EUROPE CANCER IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 39 EUROPE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 40 EUROPE ARTHRITIS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 EUROPE ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 42 EUROPE ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 43 EUROPE EPILEPSY IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 44 EUROPE EPILEPSY IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 45 EUROPE DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 46 EUROPE DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 EUROPE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 48 EUROPE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 49 EUROPE AUTISM IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 50 EUROPE AUTISM IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 52 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 53 EUROPE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 54 EUROPE ELEVATE MOOD IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 55 EUROPE OTHERS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 65 EUROPE MEDICAL CANNABIS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 66 EUROPE NATURAL IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 67 EUROPE SYNTHETIC IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 68 EUROPE MEDICAL CANNABIS MARKET, BY SPECIES, 2019-2028 (USD MILLION)

TABLE 69 EUROPE SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 70 EUROPE HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 71 EUROPE CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 72 EUROPE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 73 EUROPE ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 74 EUROPE SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 75 EUROPE TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 76 EUROPE VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 77 EUROPE OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 78 EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 79 EUROPE HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 80 EUROPE HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 81 EUROPE REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 82 EUROPE PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 83 EUROPE RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 84 EUROPE OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 85 EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 86 EUROPE B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 87 EUROPE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 88 EUROPE B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 89 EUROPE MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

TABLE 90 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 91 EUROPE TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 92 EUROPE SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 93 EUROPE SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 94 EUROPE DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 95 EUROPE TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 96 EUROPE CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 97 EUROPE SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 98 EUROPE VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 99 EUROPE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 100 EUROPE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 101 EUROPE MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 102 EUROPE MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 103 EUROPE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 104 EUROPE CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 105 EUROPE TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 106 EUROPE CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 107 EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 108 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 109 EUROPE ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 110 EUROPE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 111 EUROPE NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 112 EUROPE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 113 EUROPE CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 114 EUROPE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 115 EUROPE ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 116 EUROPE EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 117 EUROPE DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 118 EUROPE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 119 EUROPE AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 120 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 121 EUROPE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 122 EUROPE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 123 EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 124 EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 125 EUROPE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 126 GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 127 GERMANY TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 128 GERMANY SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 129 GERMANY SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 130 GERMANY DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 131 GERMANY TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 132 GERMANY CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 133 GERMANY SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 134 GERMANY VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 135 GERMANY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 136 GERMANY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 137 GERMANY MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 138 GERMANY MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 139 GERMANY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 140 GERMANY CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 141 GERMANY TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 142 GERMANY CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 143 GERMANY MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 144 GERMANY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 145 GERMANY ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 146 GERMANY MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 147 GERMANY NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 148 GERMANY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 149 GERMANY CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 150 GERMANY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 151 GERMANY ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 152 GERMANY EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 153 GERMANY DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 154 GERMANY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 155 GERMANY AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 156 GERMANY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 157 GERMANY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 158 GERMANY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 159 GERMANY MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 160 GERMANY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 161 GERMANY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 162 ITALY MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 163 ITALY TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 164 ITALY SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 165 ITALY SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 166 ITALY DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 167 ITALY TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 168 ITALY CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 169 ITALY SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 170 ITALY VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 171 ITALY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 172 ITALY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 173 ITALY MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 174 ITALY MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 175 ITALY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 176 ITALY CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 177 ITALY TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 178 ITALY CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 179 ITALY MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 180 ITALY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 181 ITALY ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 182 ITALY MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 183 ITALY NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 184 ITALY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 185 ITALY CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 186 ITALY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 187 ITALY ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 188 ITALY EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 189 ITALY DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 190 ITALY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 191 ITALY AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 192 ITALY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 193 ITALY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 194 ITALY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 195 ITALY MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 196 ITALY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 197 ITALY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 198 U.K. MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 199 U.K. TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 200 U.K. SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 201 U.K. SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 202 U.K. DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 203 U.K. TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 204 U.K. CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 205 U.K. SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 206 U.K. VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 207 U.K. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 208 U.K. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 209 U.K. MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 210 U.K. MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 211 U.K. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 212 U.K. CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 213 U.K. TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 214 U.K. CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 215 U.K. MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 216 U.K. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 217 U.K. ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 218 U.K. MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 219 U.K. NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 220 U.K. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 221 U.K. CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 222 U.K. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 223 U.K. ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 224 U.K. EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 225 U.K. DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 226 U.K. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 227 U.K. AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 228 U.K. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 229 U.K. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 230 U.K. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 231 U.K. MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 232 U.K. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 233 U.K. B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 234 NETHERLANDS MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 235 NETHERLANDS TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 236 NETHERLANDS SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 237 NETHERLANDS SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 238 NETHERLANDS DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 239 NETHERLANDS TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 240 NETHERLANDS CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 241 NETHERLANDS SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 242 NETHERLANDS VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 243 NETHERLANDS WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 244 NETHERLANDS GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 245 NETHERLANDS MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 246 NETHERLANDS MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 247 NETHERLANDS MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 248 NETHERLANDS CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 249 NETHERLANDS TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 250 NETHERLANDS CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 251 NETHERLANDS MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 252 NETHERLANDS PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 253 NETHERLANDS ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 254 NETHERLANDS MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 255 NETHERLANDS NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 256 NETHERLANDS APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 257 NETHERLANDS CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 258 NETHERLANDS ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 259 NETHERLANDS ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 260 NETHERLANDS EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 261 NETHERLANDS DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 262 NETHERLANDS MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 263 NETHERLANDS AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 264 NETHERLANDS MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 265 NETHERLANDS ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 266 NETHERLANDS MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 267 NETHERLANDS MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 268 NETHERLANDS MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 269 NETHERLANDS B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 270 SWITZERLAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 271 SWITZERLAND TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 272 SWITZERLAND SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 273 SWITZERLAND SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 274 SWITZERLAND DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 275 SWITZERLAND TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 276 SWITZERLAND CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 277 SWITZERLAND SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 278 SWITZERLAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 279 SWITZERLAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 280 SWITZERLAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 281 SWITZERLAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 282 SWITZERLAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 283 SWITZERLAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 284 SWITZERLAND CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 285 SWITZERLAND TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 286 SWITZERLAND CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 287 SWITZERLAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 288 SWITZERLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 289 SWITZERLAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 290 SWITZERLAND MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 291 SWITZERLAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 292 SWITZERLAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 293 SWITZERLAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 294 SWITZERLAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 295 SWITZERLAND ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 296 SWITZERLAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 297 SWITZERLAND DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 298 SWITZERLAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 299 SWITZERLAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 300 SWITZERLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 301 SWITZERLAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 302 SWITZERLAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 303 SWITZERLAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 304 SWITZERLAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 305 SWITZERLAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 306 FRANCE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 307 FRANCE TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 308 FRANCE SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 309 FRANCE SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 310 FRANCE DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 311 FRANCE TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 312 FRANCE CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 313 FRANCE SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 314 FRANCE VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 315 FRANCE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 316 FRANCE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 317 FRANCE MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 318 FRANCE MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 319 FRANCE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 320 FRANCE CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 321 FRANCE TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 322 FRANCE CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 323 FRANCE MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 324 FRANCE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 325 FRANCE ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 326 FRANCE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 327 FRANCE NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 328 FRANCE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 329 FRANCE CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 330 FRANCE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 331 FRANCE ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 332 FRANCE EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 333 FRANCE DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 334 FRANCE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 335 FRANCE AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 336 FRANCE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 337 FRANCE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 338 FRANCE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 339 FRANCE MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 340 FRANCE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 341 FRANCE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 342 RUSSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 343 RUSSIA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 344 RUSSIA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 345 RUSSIA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 346 RUSSIA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 347 RUSSIA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 348 RUSSIA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 349 RUSSIA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 350 RUSSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 351 RUSSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 352 RUSSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 353 RUSSIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 354 RUSSIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 355 RUSSIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 356 RUSSIA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 357 RUSSIA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 358 RUSSIA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 359 RUSSIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 360 RUSSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 361 RUSSIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 362 RUSSIA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 363 RUSSIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 364 RUSSIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 365 RUSSIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 366 RUSSIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 367 RUSSIA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 368 RUSSIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 369 RUSSIA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 370 RUSSIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 371 RUSSIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 372 RUSSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 373 RUSSIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 374 RUSSIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 375 RUSSIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 376 RUSSIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 377 RUSSIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 378 SPAIN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 379 SPAIN TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 380 SPAIN SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 381 SPAIN SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 382 SPAIN DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 383 SPAIN TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 384 SPAIN CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 385 SPAIN SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 386 SPAIN VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 387 SPAIN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 388 SPAIN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 389 SPAIN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 390 SPAIN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 391 SPAIN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 392 SPAIN CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 393 SPAIN TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 394 SPAIN CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 395 SPAIN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 396 SPAIN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 397 SPAIN ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 398 SPAIN MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 399 SPAIN NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 400 SPAIN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 401 SPAIN CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 402 SPAIN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 403 SPAIN ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 404 SPAIN EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 405 SPAIN DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 406 SPAIN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 407 SPAIN AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 408 SPAIN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 409 SPAIN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 410 SPAIN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 411 SPAIN MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 412 SPAIN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 413 SPAIN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 414 BELGIUM MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 415 BELGIUM TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 416 BELGIUM SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 417 BELGIUM SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 418 BELGIUM DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 419 BELGIUM TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 420 BELGIUM CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 421 BELGIUM SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 422 BELGIUM VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 423 BELGIUM WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 424 BELGIUM GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 425 BELGIUM MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 426 BELGIUM MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 427 BELGIUM MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 428 BELGIUM CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 429 BELGIUM TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 430 BELGIUM CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 431 BELGIUM MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 432 BELGIUM PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 433 BELGIUM ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 434 BELGIUM MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 435 BELGIUM NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 436 BELGIUM APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 437 BELGIUM CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 438 BELGIUM ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 439 BELGIUM ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 440 BELGIUM EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 441 BELGIUM DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 442 BELGIUM MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 443 BELGIUM AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 444 BELGIUM MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 445 BELGIUM ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 446 BELGIUM MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 447 BELGIUM MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 448 BELGIUM MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 449 BELGIUM B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 450 REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions